Metastatic lesions of the uterus, fallopian tubes and ovaries in undifferentiated pleomorphic sarcoma of the left tibia (clinical case)
https://doi.org/10.37748/2686-9039-2024-5-1-4
EDN: CUVQAL
Abstract
Undifferentiated pleomorphic osteosarcoma belongs to the group of rarely occurring tumors. Despite the treatment, the disease progresses in 30–40 % of patients with osteosarcomas. The main route of metastasis of bone tissue sarcomas is hematogenous, while lymphogenic spread is observed less frequently. As a rule, secondary metastatic changes occur in the lungs. Less often there is a secondary lesion of the bones of the skeleton and brain. Metastatic lesion of uterus, fallopian tubes and ovaries in malignant undifferentiated pleomorphic sarcoma is extremely rare. Therefore, we found it interesting to describe a clinical case of such a rare metastatic lesion. Patient K. underwent amputation of the left limb at the level of the lower third of the femur for undifferentiated pleomorphic sarcoma of the left tibia in 2019, and 4 courses of adjuvant polychemotherapy were performed. In 20 months after completion of complex treatment of the primary tumor, complaints of lower abdominal pain, increased body temperature up to 37.8 °C in the evenings appeared. According to the results of follow-up examination, a voluminous, multinodular, solid mass of merging character was detected in the pelvis, with total dimensions of up to 11 cm, and a cavitary mass of up to 5 cm was detected in the posterior vault. A trepan-biopsy of the mass in the projection of the right ovary was performed. The morphological picture in the volume of trepan biopsy specimens is characteristic of spindle cell sarcoma. Metastasis of undifferentiated pleomorphic bone sarcoma (malignant fibrous histiocytoma) is most likely. Due to metastatic lesions of the uterus, fallopian tubes, ovaries, omentum, mesentery and serous membrane of the colon loops, peritoneum of the bladder, surgical intervention in the volume of removal of the distal part of the sigmoid colon, rectosigmoid, upper ampullary parts of the rectum, uterus with fallopian tubes and ovaries, appendix was performed. Immunohistochemical study of the postoperative material revealed that the immunophenotype of tumor cells confirmed the morphological picture typical for undifferentiated pleomorphic bone sarcoma. The patient was further prescribed antitumor drug therapy. This clinical case demonstrates a rare, atypical metastasis of undifferentiated pleomorphic osteosarcoma, which allows to expand the knowledge about the flow of malignant diseases of this localization.
About the Authors
O. I. KitRussian Federation
Oleg I. Kit – Academician at the Russian Academy of Sciences, Dr. Sci. (Med.), professor, general director, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0003-3061-6108, SPIN: 1728-0329, AuthorID: 343182, ResearcherID: U-2241-2017, Scopus Author ID: 55994103100
Competing Interests:
the authors state that there are no conflicts of interest to disclose
E. V. Verenikina
Russian Federation
Ekaterina V. Verenikina – Dr. Sci. (Med.), head of the Department of Oncological Gynecology National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-1084-5176, SPIN: 6610-7824, AuthorID: 734269, Scopus Author ID: 57194271506
Competing Interests:
the authors state that there are no conflicts of interest to disclose
A. P. Menshenina
Russian Federation
Anna P. Menshenina – Dr. Sci. (Med.), leading researcher, Section of Reproductive Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-7968-5078, SPIN: 6845-4794, AuthorID: 715810, Scopus Author ID: 57191983118
Competing Interests:
the authors state that there are no conflicts of interest to disclose
L. Yu. Vladimirova
Russian Federation
Liubov Yu. Vladimirova – Dr. Sci. (Med.), professor, head of Tumor Drug Therapy Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-4822-5044, SPIN: 4857-6202, AuthorID: 289090, ResearcherID: U-8132-2019, Scopus Author ID: 7004401163
Competing Interests:
the authors state that there are no conflicts of interest to disclose
E. A. Kalabanova
Russian Federation
Elena A. Kalabanova – Cand. Sci. (Med.), senior researcher at the Medical Therapy Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0003-0158-3757, SPIN: 9090-3007, AuthorID: 734992, ResearcherID: V-2943-2019, Scopus Author ID: 57046062200
Competing Interests:
the authors state that there are no conflicts of interest to disclose
T. O. Lapteva
Russian Federation
Tatiana O. Lapteva – head of Pathoanatomical Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-6544-6113, SPIN: 2771-3213, AuthorID: 849370
Competing Interests:
the authors state that there are no conflicts of interest to disclose
A. A. Barashev
Russian Federation
Artem A. Barashev – Cand. Sci. (Med.), traumatologist-orthopedist, Department of Bone, Skin, Soft Tissue and Breast Tumors No. 1, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-7242-6938, SPIN: 4590-5745, AuthorID: 697517
Competing Interests:
the authors state that there are no conflicts of interest to disclose
K. S. Eremin
Russian Federation
Konstantin S. Eremin – MD, pathologist, Pathoanatomical Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0001-9331-3353, SPIN: 9865-0123, AuthorID: 1150930
Competing Interests:
the authors state that there are no conflicts of interest to disclose
A. Yu. Ardzha
Russian Federation
Anna Yu. Ardzha – Cand. Sci. (Med.), MD, oncologist, Department of Oncological Gynecology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0001-6787-3007, SPIN: 2519-7898, AuthorID: 951656
Competing Interests:
the authors state that there are no conflicts of interest to disclose
References
1. O’Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964 Nov;17:1445–1455. https://doi.org/10.1002/1097-0142(196411)17:113.0.co;2-g
2. WHO Classification of Tumors Soft Tissue and Bone Tumours. 5th ed. Lyon (France). 2020:(3). Available at: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020, Accessed: 08.11.2022.
3. Valiev A. K., Kurilchik A. A., Machak G. N., Musaev E. R., Rogozhin D. V., Sushentsov E. A. and others. Practical recommendations for the treatment of primary malignant bone tumors. Malignant tumors. 2022;12(3s2-1):307–329. (In Russ.). https://doi.org/10.18027/2224-5057-2022-12-3s2-307-329, EDN: PXBFDC
4. Laryukova EK, Laryukov AV, Burba DV, Gubaydullina FF, Galimyanov DA, Mazitova FM. Malignant fibrous histiocytoma. Approaches to differential X-ray diagnostics (case study). Practical Medicine. 2018;16(9):164–168. (In Russ.). https://doi.org/10.32000/2072-1757-2018-9-164-168, EDN: VOUJVL
5. Aljubran AH, Griffin A, Pintilie M, Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol. 2009 Jun;20(6):1136–1141. https://doi.org/10.1093/annonc/mdn731
6. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens FM. WHO Classification of tumours of soft tissue and bone. 4th ed. Lyon (France): IARC. 2013;(5). Available at: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Soft-Tissue-And-Bone-2013, Accessed: 10.11.2022.
7. Garcia Franco CE, Torre W, Tamura A, Guillén-Grima F, San-Julian M, Martin-Algarra S, et al. Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg. 2010 May;37(5):1205–1208. https://doi.org/10.1016/j.ejcts.2009.11.026
8. Vasil'ev NV. Lymph node metastasis of osteosarcomas. Arkhiv Patologii. 2016;78(4):58–63. (In Russ.). https://doi.org/10.17116/patol201678458-62
9. Layfield LJ, Emerson L, Crim JR, Randall L. Squamous differentiation and cytokeratin expression in an osteosarcoma: a case report and review of the literature. Clin Med Pathol. 2008;1:55–59. https://doi.org/10.4137/cpath.s582
10. Hatori M, Ohtani H, Yamada N, Uzuki M, Kokubun S. Synchronous multifocal osteosarcoma with lymphatic spread in the lung: an autopsy case report. Jpn J Clin Oncol. 2001 Nov;31(11):562–566. https://doi.org/10.1093/jjco/hye118
11. Akhmetbaeva AK, Suleymanov AF. Malignant fibrous histocytoma of the skull bones in hematological practice (case report). Pharmacy of Kazakhstan. 2018;(1):10–16. (In Russ.). EDN: VAUAOO
12. Kulygin BB, Chernysheva AI, Sokolova AV. Modern aspects of fibrous dysplasia. Scientific Almanac. 2017;(10-2(36)):176– 179. (In Russ.). https://doi.org/10.17117/na.2017.10.02.176, EDN: ZVHFMT
13. Izmestyeva OS, Zhavoronkov LP, Semin YuA, Posadskaya VM, Glushakova VS, Luzyanina AA, et al. Experimental evaluation of the embryotoxic effect of low-intensity ionizing radiation in different periods of intrauterine development. Radiation Biology. Radioecology. 2012;52(1):39–43. (In Russ.). EDN: OPTJDJ
14. Bone sarcomas. Clinical guidance. 2022. (In Russ.). Available at: https://cr.minzdrav.gov.ru/schema/532, Accessed: 03.12.2022
Supplementary files
Review
For citations:
Kit O.I., Verenikina E.V., Menshenina A.P., Vladimirova L.Yu., Kalabanova E.A., Lapteva T.O., Barashev A.A., Eremin K.S., Ardzha A.Yu. Metastatic lesions of the uterus, fallopian tubes and ovaries in undifferentiated pleomorphic sarcoma of the left tibia (clinical case). South Russian Journal of Cancer. 2024;5(1):34-41. https://doi.org/10.37748/2686-9039-2024-5-1-4. EDN: CUVQAL